Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 Lượt xem
• 06/28/23
0
0
Nhúng
administrator
Người đăng ký
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
Cho xem nhiều hơn
Bình luận trên Facebook
SORT BY-
Nhận xét hàng đầu
-
Bình luận mới nhất